¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Pyruvate Dehydrogenase Complex Deficiency Disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Marburg virus disease
    ¸¶¸£ºÎ¸£Å©¹ÙÀÌ·¯½ºº´
  • Marchiafava-Bignami disease
    ¸¶¸£Å°¾ÆÆÄ¹Ù-ºñ³Ä¹Ìº´
  • mast cell disease
    ºñ¸¸¼¼Æ÷º´
  • McArdle¡¯s disease
    ¸Æ¾Æµéº´
  • medullary cystic disease
    ¼ÓÁú³¶º´, ¼öÁú³¶¼ºº´
  • Menetrier disease
    ¸Þ³×Æ®¸®¿¡º´
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
  • metazoan disease
    ÈÄ»ýµ¿¹°º´
  • microdrepanocytic disease
    ÀÛÀº³´ÀûÇ÷±¸º´
  • neoplastic disease
    ½Å»ý¹°º´, Á¾¾çº´
  • nervous disease
    ½Å°æ°èÁúȯ, ½Å°æº´
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±Ù(À°)º´
  • neuropathic joint disease
    ½Å°æº´¼º°üÀýº´
  • notifiable disease
    ½Å°í´ë»óº´, ¹ß»ýº¸°íº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • occupational disease
    Á÷¾÷º´
  • occupational dental disease
    Á÷¾÷Ä¡°úº´
  • oculoglandular disease
    ´«»ùº´
  • oral disease
    ÀÔº´, ±¸°­Áúȯ
  • organic disease
    ±âÁúº´
  • pandemic disease
    ¹üÀ¯Çິ
  • panzootic disease
    µ¿¹°¹üÀ¯Çິ
  • parasitic disease
    ±â»ýÃæº´
  • paroxysmal disease
    ¹ßÀÛº´
  • pelvic inflammatory disease
    °ñ¹Ý³»°¨¿°
  • periapical disease
    Ä¡±Ù´ÜÁÖÀ§º´, Ä¡¾Æ³¡ÁÖÀ§º´
  • pericardial disease
    ½ÉÀ帷º´
  • periodontal disease
    Ä¡ÁÖº´, Ä¡±Ù¸·º´
  • peripheral vascular disease
    ¸»ÃÊÇ÷°üº´
  • pigeon breeder¡¯s disease
    ºñµÑ±â»çÀ°»çº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Takahara disease
    ´ÙÄ«Ç϶óº´
  • Takayasu disease
    Ÿī¾ß¼öº´
  • Theilers disease
    ŸÀÏ·¯¸¶¿ì½º Ư¹ß¼º ³úô¼ö¿°
  • Thornwaldts disease
    Àεγ¶¿°
  • Tietzes disease
    ƼÂź´.
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • Von Recklinghausens disease(neurofibromatosis)
    Æù·¹Å¬¸µÇÏ¿ìÁ¨º´<½Å°æ¼¶À¯Á¾Áõ>.
  • Weber Christian disease
    ¿þ¹ö-Å©¸®½º Ä£º´.
  • Weils disease
    ¿ÍÀϺ´(Ȳ´ÞÃâÇ÷¼º ·¾Å佺ÇǶóÁõ).
  • Weils disease
    ¿ÍÀϺ´(Ȳ´ÞÃâÇ÷¼º ·¾Å佺ÇǶóÁõ).
  • Weils disease
    ¿ÍÀϺ´(Ȳ´ÞÃâÇ÷¼º ·¾Å佺ÇǶóÁõ).
  • Wernicke s disease
    º£¸£´ÏÄɺ´.
  • Wernickes disease
    º£¸£´ÏÄɺ´.
  • Wilsons disease
    Àª½¼º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • organogenetic deficiency
    organogenetic deficiency
  • oxygen deficiency =o. want, o. lack, o. deprivation, o. depletion
    »ê¼ÒºÎÁ·(¡­ÝÕðë), »ê¼Ò°áÇÌ(ß«áÈÌÀù¹).
  • pantothenic acid deficiency
    ÆÇÅäÅÙ»ê°áÇÌÁõ(¡­ÌÀù¹ñø).
  • pituitary deficiency
    ÇϼöüºÎÀü(¡­ÝÕîï).
  • pituitary deficiency
    üºÎÀü(ù»á÷ô÷ÝÕîï)
  • pituitary hormone deficiency (pituitary dwarfism)
    ³úÇϼöüȣ¸£¸ó°áÇÌ (³úÇϼöü³­
  • pituitary hormone deficiency(pituitary dwarfism)
  • pituitary hormone deficiency(pituitary dwarfism)
  • plasma thromboplastin antecedent deficiency
  • protein-calorie deficiency
    ´Ü¹é(Áú)¿­·®°áÇÌ(Ó±ÛÜ(òõ)æðÕáÌÀù¹)
  • pyridoxine deficiency
    ÇǸ®µ¶½Å°áÇÌ(Áõ)(¡­ÌÀù¹(ñø))
  • reaction deficiency
    ¹ÝÀÀ°áÇÌ
  • riboflavin deficiency
    ¸®º¸Çöóºó°áÇÌ(¡­ÌÀù¹).
  • riboflavin deficiency
    ¸®º¸Çöóºó°áÇÌ(¡­ÌÀù¹)
  • secretion deficiency
    ºÐºñ°áÇÌ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
IGHD Idiopathic Growth Hormone Deficiency
MEDAC Syndrome Multiple-Endocrine Deficiency Autoimmune-Candidiasis
MR   1) Mitral Regurgitation
    = MI
  2) Minor Response...
SCID Severe Combined Immuno-Deficiency; ÁßÁõ º¹ÇÕ ¸é¿ª °áÇÌÁõ
WAGR syndrome   Wilms's Tumor
  Aniridia
  Genital Anomalies
  Me...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
DMAC Disseminated Mycobacterium avium complex
DGC Dystrophin Glycoprotein Complex
FLC Friend leukaemia complex
FV Friend virus complex
GC Golgi complex
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • peptic ulcer disease
    ¼ÒÈ­¼º ±Ë¾ç Áúȯ
  • peptic ulcerative disease
    ¼ÒÈ­¼º ±Ë¾ç Áúȯ
    Á¤¼­ÀûÀÎ ½ºÆ®·¹½º, ƯÀÌÇÑ À½½Äµé°ú ´Ù¸¥ Á¾·ùÀÇ Àڱص鿡 ÀÇÇØ °úµµÇÑ À§ »êÀÇ ºÐºñ¿¡ ÀÇÇÑ´Ù°í ¹Ï¾îÁø´Ù. °úµµÇÑ ÃâÇ÷, ºóÇ÷, õ°ø µîÀÇ ÇÕº´ÁõÀÌ ¹ß»ýÇÒ ¼öµµ ÀÖ´Ù.
  • periapical disease
    Ä¡±Ù´Ü ÁÖÀ§ Áúȯ
  • pericardial disease
    ½É³¶ Áúȯ, ½É¸· Áúȯ
  • periodontal disease
    Ä¡ÁÖ Áúȯ
  • peripheral vascular disease
    ¸»ÃÊÇ÷°ü Áúȯ
  • Perrin-Ferraton disease
    Æä·©-Æä¶óÅë º´
    µ¿ÀǾî=sna
  • Perthes' disease
    Æä¸£Å×½ºº´
  • Peutz-Jeghers-Klostermann disease
    Peutz-Jeghers-Klostermann º´
  • pick's disease
    ÇÈ Áúȯ
    ³úÀÇ µå¹® ÁøÇ༺ ÅðÇ༺ ÁúȯÀ¸·Î¼­ ¾ËÂêÇÏÀ̸Ӻ´°ú ´ë´ÜÈ÷ ºñ½ÁÇÑ ÀÓ»óÀû Áõ»ó°ú °æ°ú¸¦ ³ªÅ¸³»³ª, ¶Ñ·ÇÀÌ ´Ù¸¥ Á¶Á÷º´¸®ÇÐÀû ¼Ò°ßÀ» °¡Áö°í ÀÖ´Ù. ÇÇÁú À§ÃàÀÌ ÀüµÎ¿±°ú ÃøµÎ¿±¿¡ ±¹ÇѵǾî ÀÖÀ¸¸ç, ÅðÇàµÈ ´º·Ð¿¡´Â ±¸»óÀÇ ¼¼Æ÷Áú ³» »ç»ó ºÀÀÔü¸¦ ÇÔÀ¯Çϰí ÀÖ´Ù.
  • polycystic disease
    ´Ù³¶¼º Áúȯ
  • polycystic kidney disease
    ´Ù³¶ ½Å Áúȯ
  • polycystic ovarian disease
    ´Ù³¶ ³­¼Ò Áúȯ
  • polyendocrine autoimmune disease
    ´Ù³»ºÐºñ¼± ÀÚ°¡ ¸é¿ª Áúȯ
    µ¿ÀǾî=autoimmune
  • Pospischill-Feyrter disease
    Pospischill-Feyrter º´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
leukocyte adhesion deficiency An inherited disorder (autosomal recessive) in which there is a defective CD18 adherence complex that disturbs leukocyte chemotaxis. It is characterised by recurrent bacterial infections and impaired wound healing.
(05 Mar 2000)
leukocyte-adhesion deficiency syndrome <syndrome> Rare, autosomal recessive disorder caused by deficiency of the beta 2 integrin receptors (receptors, leukocyte-adhesion) comprising the CD11/CD18 family of glycoproteins. The syndrome is characterised by abnormal adhesion-dependent functions, especially defective tissue emigration of neutrophils, leading to recurrent infection.
(12 Dec 1998)
lipoprotein lipase deficiency, familial A rare familial condition characterised by massive chylomicronaemia and decreased levels of other lipoproteins. It is due to deficiency of lipoprotein lipase, an alkaline triglyceride hydrolase which catalyses an important step in the extrahepatic removal of triglyceride-rich lipoproteins from the blood.
(12 Dec 1998)
luteal phase deficiency Inadequate function of the corpus luteum that may prevent a fertilized egg from implanting in the uterus or may lead to early pregnancy loss.
(09 Oct 1997)
acetaldehyde dehydrogenase <enzyme> Works with both nad and nadp
Registry number: EC 1.2.1.5
Synonym: aldehyde dehydrogenase (NADP+), naho gene product
(26 Jun 1999)
acetoin dehydrogenase <enzyme> An enzyme that catalyses the conversion of acetoin to diacetyl in the presence of NAD.
Chemical name: Acetoin:NAD+ oxidoreductase
Registry number: EC 1.1.1.5
(12 Dec 1998)
acetol dehydrogenase <enzyme> Forms methylglyoxal; uses nad+
Registry number: EC 1.1.1.-
Synonym: 1-hydroxyacetone dehydrogenase
(26 Jun 1999)
acyl-ACP dehydrogenase enoyl-ACP reductase (NADPH)
acyl-CoA dehydrogenase <enzyme> See also records for specific fatty acyl groups which have full EC nomenclature number; electron-transferring flavoprotein system reducing ubiquinone and other acceptors; formerly EC 1.3.2.2
Registry number: EC 1.3.99.3
Synonym: fatty-acyl CoA dehydrogenase, palmitoyl-CoA dehydrogenase, short-chain acyl-CoA dehydrogenase, acyl-coenzyme a dehydrogenase, lauroyl-CoA oxidase
(26 Jun 1999)
acyl-CoA dehydrogenase (NADPH+) Enzyme catalyzing the reversible reduction of enoyl-CoA derivatives of chain length 4 to 16, with NADPH as the hydrogen donor, forming acyl-CoA and NADP+.
Synonym: enoyl-CoA reductase.
(05 Mar 2000)
alanopine dehydrogenase <enzyme> Catalyses reductive elimination between pyruvate and alanine, or glycine, utilizing NADH as coenzyme, producing 2,2'-iminodipropionic acid (alanopine)
Registry number: EC 1.5.1.-
(26 Jun 1999)
alcohol dehydrogenase <enzyme> An enzyme that catalyses reversibly the final step of alcoholic fermentation by reducing an aldehyde to an alcohol. In the case of ethanol, acetaldehyde is reduced to ethanol in the presence of NADH and hydrogen. The enzyme is a zinc protein which acts on primary and secondary alcohols or hemiacetals.
Chemical name: Alcohol:NAD+ oxidoreductase
Registry number: EC 1.1.1.1
(12 Dec 1998)
alcohol dehydrogenase (acceptor) An oxidoreductase that reversibly converts primary alcohols to aldehydes with an H acceptor other than NADP+.
(05 Mar 2000)
alcohol dehydrogenase (NADP+) An oxidoreductase reversibly converting alcohols to aldehydes (or ketones) with NAD(P)+ as H acceptor.
Synonym: aldehyde reductase, DPNH aldehyde transhydrogenase.
(05 Mar 2000)
aldehyde dehydrogenase <enzyme> An enzyme that oxidises an aldehyde in the presence of NAD+ and water to an acid and NADH. Before 1978, it was classified as EC 1.1.1.70.
Chemical name: Aldehyde:NAD+ oxidoreductase
Registry number: EC 1.2.1.3
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á